New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
15:28 EDTALXAAlexza Pharmaceuticals' Adasuve approved by FDA
Alexza Pharmaceuticals announced that the FDA approved Adasuve Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. Adasuve combines Alexza's proprietary Staccato delivery system with the antipsychotic drug, loxapine.
News For ALXA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ALXA

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use